Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
Clinical practice guidelines & frameworks
American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). APA.
ADHD in adults with intellectual disability (2021) UK Royal College of Psychiatrists . CR 230.
Australian Evidence Based Clinical Practice Guidelines for ADHD and Aboriginal and Torres Strait Islander Peoples
European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. BMC Psychiatry 2010 10:67.
Australian ADHD Professionals Association (AADPA) - Australian Evidence-Based Guideline Clinical Guideline for ADHD (2022
AADPA. (2022). ADHD stimulant prescribing regulations & authorities in Australia & New Zealand
Canadian ADHD Resource Alliance (CADDRA). (2018). Canadian ADHD Practice Guidelines, Fourth Edition. Toronto ON: CADDRA.
Kooij, J. J., Franken, M. H., & Bron, T. I. (2019). DIVA-5 Diagnostic Interview for ADHD in Adults (3rd Edition; DIVA-5).
Kooij, J. J. S., Bijlenga, D., Salerno, L., Jaeschke, R., Bitter, I., Balazs, J., . . . Asherson, P. (2019). Updated European Consensus Statement on diagnosis and treatment of adult ADHD. European Psychiatry, 56, 14-34.
WEISS Functional Impairment Rating Scale Diagnostic Validity
Royal Australasian College of Physicians. (2009). Australian guidelines on attention deficit hyperactivity disorder. In: RACP. Royal Australia and New Zealand College of Psychiatrists. (2013). The role of a psychiatrist in Australia and New Zealand: Position Statement 80. RANZCP
Weisler, R., Ginsberg, L., Dirks, B., Deas, P., Adeyi, B., & Adler, L. A. (2017). Treatment With Lisdexamfetamine Dimesylate Improves Self- and Informant-Rated Ex ecutive Function Behaviors and Clinician- and Informant- Rated ADHD Symptoms in Adults: Data From a Randomized, Double-Blind, Placebo-Contr olled Study. J Atten Disord, 21(14), 1198-1207.
Royal Australian & New Zealand College of Psychiatrists. (2021). Position statement 62: Partnering with people with a lived experience. In: RANZCP.
Faraone, S. V., Banaschewski, T., Coghill, D., Zheng, Y., Biederman, J., Bellgrove, M. A., . . . Wang, Y. (2021). The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disor der. Neurosci Biobehav Rev, 128, 789-818.
Adler, L. A., Dirks, B., Deas, P. F., Raychaudhuri, A., Dauphin, M. R., Lasser, R. A., & Weisler, R. H. (2013). Lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorder who report clinically significant impairment in executive function: results from a randomized, double-blind, placebo-contr olled study. J Clin Psychiatry, 74(7), 694-702
Diaz-Roman, A., Mitchell, R., & Cor tese, S. (2018). Sleep in adults with ADHD: Systematic review and meta-analysis of subjective and objective studies. Neuroscience and Biobehavioral Reviews, 89, 61-71.
The Barkley Deficits in Executive Functioning Scale (BDEFS)
Barkley, R. A. (2014). The assessment of executive functioning using the Barkley Deficits in Executive Functioning Scales.
Rösler M, Retz W, Thome J, et al (2006) Psychopathological rating scales for diagnostic use in adults with attention-deficit/hyperactivity disorder (ADHD). European Archives of Psychiatry and Clinical Neuroscience, 256 (Suppl 1): i3–11.
CADDRA (2014) Weiss Functional Impairment Rating Scale – SELF REPORT (WFIRS-S). Canadian ADHD Resource Alliance (https://www.caddra.ca/ pdfs/caddraGuidelines2011WFIRS_S.pdf).
Weiss MD, Brooks BL, Iverson GL, et al (2007) Reliability and Validity of the Weiss Functional Impairment Rating Scale. World Psychiatric Association Shanghai Regional Meeting and CSP Annual Congress. September 20–23, 2007; Shanghai, China.
Barkley RA (2007) Barkley’s Quick-Check for Adult ADHD Diagnosis. Jones and Bartlett.
Barkley RA, Murphy KR (2006) Attention Deficit Hyperactivity Disorder: A Clinical Workbook (3rd edn) Guilford Press.
Faraone SV, Biederman J (2005) What is the prevalence of adult ADHD? Results of a population screen of 966 adults. Journal of Attention Disorders, 9: 384–91.
Murphy K, Barkley RA (1996) Attention deficit hyperactivity disorder adults: comorbidities and adaptive impairments. Comprehensive Psychiatry, 37: 393–401.
Royal College of Psychiatrists in Scotland, Addressing The Balance (2012) Helping ADHD Adults in Scotland. Royal College of Psychiatrists.
National Institute for Health and Care Excellence (NICE) clinical guideline CG72 (NICE, 2008)
The British Association of Psychopharmacology’s guidelines (Bolea-Alamañac et al, 2014)
Criteria and Concurrent Validity of DIVA 2.0: A Semi-Structured Diagnostic Interview for Adult ADHD.
Journal of Attention Disorders. 2019 Aug;23(10):1126-1135. doi: 10.1177/1087054716646451
Ethical Guidelines: Principles and Guidelines for Aboriginal and Torres Strait Islander Mental Health.
The Royal Australian & New Zealand College of Psychiatrists.
Working Together: Aboriginal and Torres Strait Islander Mental Health and Wellbeing Principles and Practice. (2nd ed). Commonwealth of Australia (2014).
NICE guideline [NG87] National Health Service 2018. Attention deficit hyperactivity disorder: diagnosis and management . Published: 14 March 2018 Last updated: 13 September 2019
NICE guideline [NG87] National Health Service 2021.
Exceptional surveillance of attention deficit hyperactivity disorder: diagnosis and management (NICE guideline NG87)
The Royal Australian and New Zealand College of Psychiatrists (RANZCP) position Statement on ADHD across the lifespan. Updated March 2023
Guidance to Support Gender Affirming Care for Mental Health by the Office for Mental Health and Well-being, ACT Health
Diagnostic decisions are made using the Diagnostic and Statistical Manual for Mental Disorders, fifth edition text revision (DSM-5-TR)
Novel Treatment for Depression
One third of patients with Major Depressive Disorder experience treatment-resistant depression (TRD) and do not achieve full remission despite multiple adequate trials of antidepressant treatment (McIntyre et al., 2014; Trevino
N-methyl-d-aspartate (NMDA) receptor antagonist, has recently emerged as a safe and effective novel treatment for people with TRD with rapid antidepressant effects et al., 2014).
Cognitive impairment is more common in people with TRD (Lopez-Sola et al., 2020), and is associated with poorer social and occupational functioning and quality of life (Cambridge et al., 2018;
RMC delivers the KAP treatment intervention for Treatment Resistant Depression in
select Clinic rooms of selected Clinical Psychologists (with Doctorates in Psychology) in ACT.
The intervention is delivered by the Psychiatrist, Clinical Psychologist and Registered Nurse.
RMC undertakes this treatment with strict medical and nursing policies and procedures and medical equipment onsite along with a Registered Nurse present.
Typically the number of sessions is between 6 and 8.
The treatment has different methods of transmission .
Guidelines & Regulatory Frameworks
All treatment pathways strictly follow :
The Black Dog KSET measurement-based safety monitoring system which capture acute, cumulative and longer term side effects.
The Royal Australian College of Psychiatrists
Clinical Practice Guidelines for Mood Disorders.
Australian & New Zealand Journal of Psychiatry
2021, Vol. 55(1) 7–117.
© The Royal Australian and
New Zealand College of Psychiatrists
The Royal Australian College of Psychiatrists Professional Practice Guideline 4
PPG 4 PPP ‘Off-label’ prescribing in psychiatry.
© The Royal Australian and
New Zealand College of Psychiatrists
RANZCP Clinical Memorandum CLM PPR (July 2022) is followed for the psychiatric treatment pathway
for Treatment Resistant Depression
RMC uses Canberra Script and Safe Script NSW
Dr Lewis is an authorised prescriber of Schedule 8 *Medication as listed in The Medicines, Poisons & Therapeutic Goods Act 2008.
This pathway uses a medical model embracing Novel Therapies and administration of a Schedule 8 *Medication over 6 or 8 sessions.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.